Sunflower Pharmaceutical (SHE:002737) withdrew its 1-million-yuan investment in the Hangzhou Xiaochi Fund and will transfer its partnership share to an individual investor, according to a Tuesday filing with the Shenzhen bourse.
The sale to individual investor Wu Mingxing will help the company focus on its core operations, improve its investment structure, and boost capital operations efficiency.